Original Research

Accepted on 14 Nov 2024

Developing a Digital Phenotype to Subdivide Adult Immunosuppressed COVID-19 outcomes within the English Primary Care Sentinel Network

in Vaccines and Molecular Therapeutics

Meredith Leston
Debasish Kar
Gavin Jamie
Anna Forbes
Rashmi Wimalaratna
Gunjan Jiwani
José Ordóñez-Mena
Daniel E Stewart
Heather Whitaker
Mark Joy

Frontiers in Immunology

doi 10.3389/fimmu.2024.1491565

Original Research

Accepted on 13 Nov 2024

Promotion of Angiogenesis and Suppression of Inflammatory Response in Skin Wound Healing Using Exosome-Loaded Collagen Sponge

in Vaccines and Molecular Therapeutics

Siqi Zhang
Xugang Lu
Jun Chen
Shibing Xiong
Yifan Cui
Simeng Wang
Chongxia Yue
Han Qianqian
Bangcheng Yang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1511526

Original Research

Published on 13 Nov 2024

Comparison of antibody responses of heterologous and homologous Covid-19 booster vaccination: an observational study

in Vaccines and Molecular Therapeutics

Nayab Batool Rizvi
Maryam Bibi
Muhmmad Zeeshan Rana
Sehrish Zaffar
Hassam Farooq

Frontiers in Immunology

doi 10.3389/fimmu.2024.1448408

2,795 views

Original Research

Accepted on 12 Nov 2024

Intranasal trivalent candidate vaccine induces strong mucosal and systemic immune responses against Neisseria gonorrhoeae

in Vaccines and Molecular Therapeutics

Qin Lu
Hui Yang
Yanfeng Peng
Zeling Dong
Pujing Nie
Guangli Wang
Shilu Luo
Xun Min
Jian Huang
Meirong Huang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1473193

Original Research

Accepted on 11 Nov 2024

Respiratory Syncytial Virus Vaccination Among US Adults Aged ≥60 Years

in Vaccines and Molecular Therapeutics

Xiaozhen Geng
Wenjun Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1427550

Original Research

Accepted on 11 Nov 2024

Seroprevalence study reveals pertussis underreporting in Brazil and calls for adolescent/young adult boosting: mouse model demonstrates immunity restoration

in Vaccines and Molecular Therapeutics

Eliane P Silva
Monalisa Trentini
Dunia Rodriguez
Alex I Kanno
Filumena M S Gomes
Maria H Valente
Carlos E M Trufen
Lais S Yamamoto
Arthur D Januzzi
Priscila S Cunegundes

Frontiers in Immunology

doi 10.3389/fimmu.2024.1472157

Original Research

Published on 11 Nov 2024

Immunogenicity of dupilumab in adult and pediatric patients with atopic dermatitis

in Vaccines and Molecular Therapeutics

Mohamed A. Kamal
Matthew P. Kosloski
Ching-Ha Lai
Michael A. Partridge
Manoj Rajadhyaksha
Vanaja Kanamaluru
Ashish Bansal
Arsalan Shabbir
Brad Shumel
Marius Ardeleanu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1466372

558 views

Original Research

Accepted on 08 Nov 2024

A multi-antigen vaccinia vaccine broadly protected mice against SARS-CoV-2 and influenza A virus while also targeting SARS-CoV-1 and MERS-CoV

in Vaccines and Molecular Therapeutics

Nan Gao
Tianhan Yang
Lanlan Dong
Wanda Tang
Kangli Cao
Longfei Ding
Cuisong Zhu
Shimeng Bai
Ai Xia
Chen Zhao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1473428

Review

Published on 08 Nov 2024

Personalized cancer vaccine design using AI-powered technologies

in Vaccines and Molecular Therapeutics

Anant Kumar
Shriniket Dixit
Kathiravan Srinivasan
Dinakaran M
P. M. Durai Raj Vincent

Frontiers in Immunology

doi 10.3389/fimmu.2024.1357217

746 views

Review

Published on 07 Nov 2024

Enhancing broadly neutralising antibody suppression of HIV by immune modulation and vaccination

in Vaccines and Molecular Therapeutics

John Frater
Carla Nel

Frontiers in Immunology

doi 10.3389/fimmu.2024.1478703

514 views

Clinical Trial

Published on 07 Nov 2024

Safety, immunogenicity and immune-persistence of a lyophilized human rabies vaccine (Vero cells) under Zagreb and Essen regimens: a randomized, open-label, controlled phase III clinical trial in healthy participants aged 10–60 years in China

in Vaccines and Molecular Therapeutics

Huakun Lv
Zhenzhen Liang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1444686

266 views

Original Research

Published on 06 Nov 2024

Determination of immunogenicity of an inactivated ND-vaccine developed experimentally with Newcastle disease virus (Genotype VII.2) local isolates of Bangladesh

in Vaccines and Molecular Therapeutics

Md. Alimul Islam
Muhammad Tofazzal Hossain
Mst. Minara Khatun
Mohammad Sadekuzzaman
Dr. Md. Enamul Haque
Mohammad Aynul Haque

Frontiers in Immunology

doi 10.3389/fimmu.2024.1482314

283 views

Original Research

Published on 06 Nov 2024

Clinical characteristics and antibody response to Omicron variants among solid carcinoma patients in China on the 2022.12–2023.4 wave of the COVID-19 pandemic

in Vaccines and Molecular Therapeutics

Hangjie Zhang
Fang He
Jianmin Jiang
Qianhui Hua
娜妮徐

Frontiers in Immunology

doi 10.3389/fimmu.2024.1476186

363 views

Review

Accepted on 05 Nov 2024

Advances in protein subunit vaccines against H1N1/09 influenza

in Vaccines and Molecular Therapeutics

Yu Zhang
Jingyao Gao
Wenqi Xu
Xingyu Huo
Jingyan Wang
Yirui Xu
Wenting Ding
Zeliang Guo
Rongzeng Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1499754

158 views

Original Research

Published on 05 Nov 2024

Neutrophil-activating protein in Bacillus spores inhibits casein allergy via TLR2 signaling

in Vaccines and Molecular Therapeutics

Zhuwei Liang
Chao Zhang
Xiaoyu Liu
Kaiyue Yang
Zhile Xiong
Bingshao Liang
Jialiang Mai
Xiaojun Xiao
Jie Liu
Pingchang Yang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1428079

287 views

Original Research

Accepted on 04 Nov 2024

Immunosuppressants in Dermatology on Vaccine Immunogenicity: A Prospective Cohort Study of Pemphigus Patients in the Pandemic

in Vaccines and Molecular Therapeutics

Kun Lin Lu
Hua En Lee
Chun-Bing Chen
Chung-Yee Rosaline Hui
Ya-Ching Chang
Chun-Wei Lu
Chuang-Wei Wang
Wen-Hung Chung

Frontiers in Immunology

doi 10.3389/fimmu.2024.1506962

Navigation group

Articles

Developing a Digital Phenotype to Subdivide Adult Immunosuppressed COVID-19 outcomes within the English Primary Care Sentinel Network

Promotion of Angiogenesis and Suppression of Inflammatory Response in Skin Wound Healing Using Exosome-Loaded Collagen Sponge

Comparison of antibody responses of heterologous and homologous Covid-19 booster vaccination: an observational study

Intranasal trivalent candidate vaccine induces strong mucosal and systemic immune responses against Neisseria gonorrhoeae

Respiratory Syncytial Virus Vaccination Among US Adults Aged ≥60 Years

Seroprevalence study reveals pertussis underreporting in Brazil and calls for adolescent/young adult boosting: mouse model demonstrates immunity restoration

Immunogenicity of dupilumab in adult and pediatric patients with atopic dermatitis

A multi-antigen vaccinia vaccine broadly protected mice against SARS-CoV-2 and influenza A virus while also targeting SARS-CoV-1 and MERS-CoV

Personalized cancer vaccine design using AI-powered technologies

Enhancing broadly neutralising antibody suppression of HIV by immune modulation and vaccination

Safety, immunogenicity and immune-persistence of a lyophilized human rabies vaccine (Vero cells) under Zagreb and Essen regimens: a randomized, open-label, controlled phase III clinical trial in healthy participants aged 10–60 years in China

Determination of immunogenicity of an inactivated ND-vaccine developed experimentally with Newcastle disease virus (Genotype VII.2) local isolates of Bangladesh

Clinical characteristics and antibody response to Omicron variants among solid carcinoma patients in China on the 2022.12–2023.4 wave of the COVID-19 pandemic

Advances in protein subunit vaccines against H1N1/09 influenza

Neutrophil-activating protein in Bacillus spores inhibits casein allergy via TLR2 signaling

Immunosuppressants in Dermatology on Vaccine Immunogenicity: A Prospective Cohort Study of Pemphigus Patients in the Pandemic